| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 910862
[patent_doc_number] => 07329796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-12
[patent_title] => 'Serial nuclear transfer of ungulate embryos'
[patent_app_type] => utility
[patent_app_number] => 10/909845
[patent_app_country] => US
[patent_app_date] => 2004-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6816
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329796.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909845
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909845 | Serial nuclear transfer of ungulate embryos | Aug 2, 2004 | Issued |
Array
(
[id] => 6991404
[patent_doc_number] => 20050090441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Inhibition of neurodegeneration'
[patent_app_type] => utility
[patent_app_number] => 10/910173
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17365
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090441.pdf
[firstpage_image] =>[orig_patent_app_number] => 10910173
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/910173 | Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition | Aug 1, 2004 | Issued |
Array
(
[id] => 7264940
[patent_doc_number] => 20040242476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Male contraceptives'
[patent_app_type] => new
[patent_app_number] => 10/481279
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11360
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481279
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481279 | Male contraceptives | Jul 6, 2004 | Abandoned |
Array
(
[id] => 7206430
[patent_doc_number] => 20050043265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'High affinity RNA ligands of basic fibroblast growth factor'
[patent_app_type] => utility
[patent_app_number] => 10/885403
[patent_app_country] => US
[patent_app_date] => 2004-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12893
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043265.pdf
[firstpage_image] =>[orig_patent_app_number] => 10885403
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/885403 | High affinity RNA ligands of basic fibroblast growth factor | Jul 5, 2004 | Issued |
Array
(
[id] => 7234492
[patent_doc_number] => 20050079616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Method of transducing ES cells'
[patent_app_type] => utility
[patent_app_number] => 10/876071
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8820
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079616.pdf
[firstpage_image] =>[orig_patent_app_number] => 10876071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876071 | Method of transducing ES cells | Jun 23, 2004 | Abandoned |
| 10/875104 | Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby | Jun 22, 2004 | Abandoned |
Array
(
[id] => 7084015
[patent_doc_number] => 20050049395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Models of prion disease'
[patent_app_type] => utility
[patent_app_number] => 10/875821
[patent_app_country] => US
[patent_app_date] => 2004-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12501
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049395.pdf
[firstpage_image] =>[orig_patent_app_number] => 10875821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/875821 | Models of prion disease | Jun 22, 2004 | Abandoned |
Array
(
[id] => 6932972
[patent_doc_number] => 20050283843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Novel nuclear transfer technique through the processes of enucleation after activation to produce cloned mammals'
[patent_app_type] => utility
[patent_app_number] => 10/869427
[patent_app_country] => US
[patent_app_date] => 2004-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8034
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0283/20050283843.pdf
[firstpage_image] =>[orig_patent_app_number] => 10869427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/869427 | Novel nuclear transfer technique through the processes of enucleation after activation to produce cloned mammals | Jun 15, 2004 | Abandoned |
Array
(
[id] => 7063726
[patent_doc_number] => 20050005318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Compositions and methods for the efficient and reproducible generation of clone animals of all developmental stages and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/865369
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14494
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20050005318.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865369
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865369 | Enhanced production of cloned mammals by zona pellucida-free homologous mammalian embryo aggregation | Jun 9, 2004 | Issued |
Array
(
[id] => 602651
[patent_doc_number] => 07432414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-07
[patent_title] => 'Transgenic mouse having an amyloid precursor protein with a modified beta secretase cleavage site'
[patent_app_type] => utility
[patent_app_number] => 10/558656
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 14962
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/432/07432414.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558656 | Transgenic mouse having an amyloid precursor protein with a modified beta secretase cleavage site | May 27, 2004 | Issued |
Array
(
[id] => 5892337
[patent_doc_number] => 20060277616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Method for cloning of the rat by nuclear transfer'
[patent_app_type] => utility
[patent_app_number] => 10/556873
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5459
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20060277616.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556873
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556873 | Method for cloning of the rat by nuclear transfer | May 23, 2004 | Issued |
Array
(
[id] => 5101749
[patent_doc_number] => 20070185011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'C1 inhibitor with short half-life transient treatment'
[patent_app_type] => utility
[patent_app_number] => 10/557026
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3661
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557026 | C1 inhibitor with short half-life transient treatment | May 13, 2004 | Issued |
Array
(
[id] => 8408677
[patent_doc_number] => RE043691
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2012-09-25
[patent_title] => 'C1 inhibitor with short half-life transient treatment'
[patent_app_type] => reissue
[patent_app_number] => 13/157176
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3661
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13157176
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/157176 | C1 inhibitor with short half-life transient treatment | May 13, 2004 | Issued |
Array
(
[id] => 823870
[patent_doc_number] => 07405342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-29
[patent_title] => 'Transgenic mice expressing heterologous complement receptor type 1 (CR1) molecules on erythrocytes and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/843038
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18143
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/405/07405342.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843038
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843038 | Transgenic mice expressing heterologous complement receptor type 1 (CR1) molecules on erythrocytes and uses therefor | May 9, 2004 | Issued |
Array
(
[id] => 7070059
[patent_doc_number] => 20050245444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Method of using recombinant human antithrombin for neurocognitive disorders'
[patent_app_type] => utility
[patent_app_number] => 10/835836
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 34836
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835836
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835836 | Method of using recombinant human antithrombin for neurocognitive disorders | Apr 29, 2004 | Abandoned |
| 10/833994 | Cloning using donor nuclei from somatic cells | Apr 27, 2004 | Abandoned |
| 10/833993 | CICM cells and non-human mammalian embryos prepared by nuclear transfer of a differentiated cell or its nucleus | Apr 27, 2004 | Abandoned |
Array
(
[id] => 7473578
[patent_doc_number] => 20040199935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Cytoplasmic transfer to de-differentiate recipient cells'
[patent_app_type] => new
[patent_app_number] => 10/831599
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6880
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20040199935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831599
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831599 | Cytoplasmic transfer to de-differentiate recipient cells | Apr 22, 2004 | Abandoned |
Array
(
[id] => 7419582
[patent_doc_number] => 20040177390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Method of nuclear transfer'
[patent_app_type] => new
[patent_app_number] => 10/475168
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13890
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20040177390.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475168
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475168 | Method of nuclear transfer | Apr 20, 2004 | Abandoned |
Array
(
[id] => 7250237
[patent_doc_number] => 20050074439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson\'s disease'
[patent_app_type] => utility
[patent_app_number] => 10/818486
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21798
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10818486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/818486 | Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease | Apr 4, 2004 | Abandoned |
